首页 | 本学科首页   官方微博 | 高级检索  
     

T1-2N1M0早期乳腺癌术后放射治疗的研究进展
引用本文:周楠,许庆勇. T1-2N1M0早期乳腺癌术后放射治疗的研究进展[J]. 现代肿瘤医学, 2021, 0(20): 3681-3684. DOI: 10.3969/j.issn.1672-4992.2021.20.037
作者姓名:周楠  许庆勇
作者单位:哈尔滨医科大学附属肿瘤医院乳腺放疗科,黑龙江 哈尔滨 150086
基金项目:黑龙江省哈尔滨市科技局科技创新人才研究专项资金(编号:2017RAXXJ049);哈尔滨医科大学附属肿瘤医院海燕科研基金(编号:JJ2D2018-04)
摘    要:乳腺癌是危害女性健康的常见疾病,术后放疗(PMRT)可以提高患者生存率,减少乳腺癌转移及复发率,是治疗乳腺癌的重要方法.术后放疗对1~3个淋巴结阳性乳腺癌的治疗效果及预后影响仍是当前的讨论热点.本文就高危因素、分子分型、21基因检测、预后营养指数等对T1-2 N1 M0早期乳腺癌术后放疗的指导意义作一综述.

关 键 词:乳腺癌  放射治疗  1~3淋巴结转移  高危因素  分子分型

Research progress of postoperative radiotherapy for early breast cancer of T1-2N1M0
ZHOU Nan,XU Qingyong. Research progress of postoperative radiotherapy for early breast cancer of T1-2N1M0[J]. Journal of Modern Oncology, 2021, 0(20): 3681-3684. DOI: 10.3969/j.issn.1672-4992.2021.20.037
Authors:ZHOU Nan  XU Qingyong
Affiliation:Department of Breast Radiotherapy,Harbin Medical University Cancer Hospital,Heilongjiang Harbin 150086,China.
Abstract:Breast cancer is a common disease harmful to women's health.Postoperative radiotherapy (PMRT) can improve the survival rate of patients and reduce the metastasis and recurrence rate of breast cancer,which is an important method to treat breast cancer.However,the effect of postoperative radiotherapy on the treatment and prognosis of 1~3 lymph node positive breast cancer is still a hot topic.This article reviews the significance of high risk factors,molecular typing,21 gene detection and prognostic nutrition index on postoperative radiotherapy of T1-2N1M0 early breast cancer.
Keywords:breast cancer   radiotherapy   1~3 lymph node metastasis   risk factors   molecular typing
点击此处可从《现代肿瘤医学》浏览原始摘要信息
点击此处可从《现代肿瘤医学》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号